Common (>1/100): Gastrointestinal Disorders: nausea, vomiting, diarrhoea.
Uncommon (≥ 1/1 000 to <1/100): Immune System Disorders: dermatitis allergic.
Post-market Surveillance: The following adverse events have been reported in association with tranexamic acid therapy.
Nervous System Disorders: convulsion, dizziness.
Eye Disorders: chromatopsia, visual impairment.
Vascular Disorders: embolism, hypotension (after fast injection).
View ADR Monitoring Form